title: [Turner Syndrome: what's new in medical care?].
abstract: Turner syndrome is a rare genetic disorder, affecting approximately one in 2500 live-born female, due to total or partial absence of the X chromosome. Typical clinical features are short stature and premature ovarian failure and less constantly phenotypic particularities such as congenital malformations, acquired cardiovascular, otological (hearing impairment), autoimmune and metabolic pathologies. The phenotype is highly variable with slight or even normal phenotype. Several studies have shown that growth hormone treatment improves adult height. The possibility of pregnancies after oocyte donation highlights the high risk of these pregnancies requiring a careful follow-up, especially in terms of cardiovascular issues. Although the quality of life seems similar to the normal population, the presence of cardiovascular and otological diseases, and delayed feminisation are associated with an impaired quality of life. Early diagnosis and regular screening for potentials associated complications are essential in the medical follow-up of these patients. The recent publication of recommendations should lead to an optimization and harmonisation of the medical practices and follow-up from paediatric age to adulthood, a lowering morbidity and self-esteem improvement. The interest of ovarian cryopreservation at an early age in these patients is under investigation.
authors: Inserm UMR, service endocrinologie-diabétologie pédiatrique, centre référence maladies endocriniennes rares de la croissance, université Paris-Diderot, hôpital Robert-Debré, Assistance publique-Hôpitaux de Paris, France. delphine.zenaty@rdb.aphp.fr
authors: D
authors: D
authors: Zenaty
authors: M
authors: M
authors: Laurent
authors: J C
authors: JC
authors: Carel
authors: J
authors: J
authors: Léger
mesh_terms: D000328:Adult; D002318:Cardiovascular Diseases / Q000235:genetics; D041321:Chromosomes, Human, X; D042241:Early Diagnosis; D015914:Estrogen Replacement Therapy / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D005602:France / Q000453:epidemiology; D013006:Growth Hormone / Q000627:therapeutic use; D034381:Hearing Loss / Q000235:genetics; D006801:Humans; D059785:Karyotype; D010348:Patient Care Team; D010641:Phenotype; D017410:Practice Guidelines as Topic; D015995:Prevalence; D016649:Primary Ovarian Insufficiency / Q000188:drug therapy / Q000235:genetics; D011788:Quality of Life; D012307:Risk Factors; D014424:Turner Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000235:genetics*
chemical_list: D013006:Growth Hormone